Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells

J Cell Mol Med. 2015 Aug;19(8):1900-9. doi: 10.1111/jcmm.12562. Epub 2015 Mar 5.

Abstract

This study investigated the presence of cell membrane docking proteins synaptosomal-associated protein, 25 and 23 kD (SNAP-25 and SNAP-23) in satellite glial cells (SGCs) of rat trigeminal ganglion; whether cultured SGCs would release glutamate in a time- and calcium-dependent manner following calcium-ionophore ionomycin stimulation; and if botulinum neurotoxin type A (BoNTA), in a dose-dependent manner, could block or decrease vesicular release of glutamate. SGCs were isolated from the trigeminal ganglia (TG) of adult Wistar rats and cultured for 7 days. The presence of SNAPs in TG sections and isolated SGCs were investigated using immunohistochemistry and immunocytochemistry, respectively. SGCs were stimulated with ionomycin (5 μM for 4, 8, 12 and 30 min.) to release glutamate. SGCs were then pre-incubated with BoNTA (24 hrs with 0.1, 1, 10 and 100 pM) to investigate if BoNTA could potentially block ionomycin-stimulated glutamate release. Glutamate concentrations were measured by ELISA. SNAP-25 and SNAP-23 were present in SGCs in TG sections and in cultured SGCs. Ionomycin significantly increased glutamate release from cultured SGCs 30 min. following the treatment (P < 0.001). BoNTA (100 pM) significantly decreased glutamate release (P < 0.01). Results from this study demonstrated that SGCs, when stimulated with ionomycin, released glutamate that was inhibited by BoNTA, possibly through cleavage of SNAP-25 and/or SNAP-23. These novel findings demonstrate the existence of vesicular glutamate release from SGCs, which could potentially play a role in the trigeminal sensory transmission. In addition, interaction of BoNTA with non-neuronal cells at the level of TG suggests a potential analgesic mechanism of action of BoNTA.

Keywords: SNAP-23; SNAP-25; botulinum neurotoxin type A; glutamate; ionomycin; pain; satellite glial cells; trigeminal ganglion; vesicular release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Botulinum Toxins, Type A / pharmacology*
  • Cells, Cultured
  • Glutamic Acid / metabolism*
  • Immunohistochemistry
  • Ionomycin / pharmacology
  • Male
  • Neuroglia / drug effects
  • Neuroglia / metabolism*
  • Rats, Wistar
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / metabolism*
  • Synaptosomal-Associated Protein 25 / metabolism
  • Time Factors
  • Trigeminal Ganglion / cytology
  • Trigeminal Ganglion / metabolism
  • Vesicular Transport Proteins / metabolism

Substances

  • Snap23 protein, rat
  • Synaptosomal-Associated Protein 25
  • Vesicular Transport Proteins
  • Glutamic Acid
  • Ionomycin
  • Botulinum Toxins, Type A